Navigation Links
PDL BioPharma Announces First Quarter 2012 Financial Results
Date:5/3/2012

fully diluted shares, net of estimated taxes

271,275Non-GAAP income used to compute non-GAAP net income per diluted share

$41,807$45,820Shares used to compute non-GAAP net income per diluted share

140,204184,954Non-GAAP net income per diluted share

$
.30$
.25 PDL BIOPHARMA, INC. GENERAL AND ADMINISTRATIVE EXPENSE DATA(Unaudited)(In thousands) Three Months Ended
March 31,(Dollars in thousands)20122011Compensation and benefits$   1,124$
942Legal expense3,5293,495Professional services1,029568Stock-based compensation20450All Other1,059724Total general and administrative expenses$   6,945$   5,779 PDL BIOPHARMA, INC. CONDENSED CONSOLIDATED BALANCE SHEET DATA(Unaudited)(In thousands) March 31,
2012December 31,
2011Cash, cash equivalents and investments$
92,512$
227,946Total assets$
234,963$
269,471Non-recourse notes payable$
9,531$
93,370Convertible notes payable$
302,241$
316,615Total stockholders' deficit$
(243,780)$
(204,273) PDL BIOPHARMA, INC. CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOW DATA (Unaudited)(In thousands) Three Months Ended March 31,20122011Net income$  40,184$  44,545Adjustments to reconcile net income to net cash provided by operating activities6,2152,409Changes in assets and liabilities(28,503)(60,106)Net cash provided by operating activities$  17,896$ (13,152) PDL BIOPHARMA, INC. MIX OF EX-U.S. SALES AND EX-U.S.-BASED MANUFACTURING AND SALES(Unaudited)Three Months Ended March 31,20122011Avastin% Ex-U.S. Sold57%56%% Ex-U.S.-based Manufactured and Sold

27%19%Herceptin% Ex-U.S. Sold70%71%% Ex-U.S.-based Manufactured and Sold

35%40%Lucentis% Ex-U.S. Sold60%57%% Ex-U.S.-based Manufactured and Sold

0%0%Xolair% Ex-U.S. Sold40%39%% Ex-U.S.-based Manufactured and Sold

40%39%
'/>"/>

SOURCE PDL BioPharma, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related biology technology :

1. Inspiration Biopharmaceuticals Announces Filing of Biologics License Application (BLA) for IB1001, a Recombinant Factor IX Product for People with Hemophilia B
2. Genesis Biopharma Announces Proposed Public Offering of Common Stock and Warrants
3. Laureate Biopharma Names James D. Utterback to Board of Directors
4. Enox Biopharma, Inc. Will Present at IN360 Investment in Innovation Conference
5. PDL BioPharma Announces Fourth Quarter and Full Year 2011 Financial Results
6. Laureate Biopharma Appoints Les Mintzmyer, Vice President, Operations
7. Galien Foundation Announces 2012 Awards Program For Best Biopharmaceutical Products and Best Medical Technology
8. Sigma-Aldrich to Acquire BioReliance; Extending Its Reach into Biopharmaceutical Testing and Services
9. HealthCare Institute of New Jersey Releases 2011 Biopharmaceutical and Medical Technology Economic Impact Data
10. Keryx Biopharmaceuticals to Present at JP Morgans 30th Annual Healthcare Conference
11. Inspiration Biopharmaceuticals Moves Corporate Headquarters to Cambridge, Massachusetts
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/19/2014)... (PRWEB) December 19, 2014 BioPlus ... specialty pharmacies, announces the promotion of Nick Maroulis, Pharm.D. ... Specialty Pharmacy Services. , In this position, Dr. ... while also managing the directors of our multi-site pharmacies ... BioPlus since 1997 and during that time he has ...
(Date:12/19/2014)... PLEASANTON, Calif. , Dec. 19, 2014  Roche ... acquisition of Bina Technologies, Inc. (Bina), a privately ... California , USA. Bina provides a big ... next generation sequencing (NGS) data. Bina,s proprietary on-market ... translational and academic researchers to perform fast and ...
(Date:12/19/2014)... -- Decision Resources Group finds that the Latin American ... compound annual growth rate through 2023. This is primarily ... increasing adoption of dental implants. Growing aesthetic consciousness in ... demand for dental biomaterials because they can improve the ... Other key findings from Decision Resources Group,s coverage ...
(Date:12/19/2014)... Springs, FL (PRWEB) December 18, 2014 ... of the nation’s leading specialty pharmacies, has an ... serve as clinical pharmacy consultants for prescriber offices ... therapy expertise. , “We have a variety ... therapies. For example, those specializing in hepatitis C ...
Breaking Biology Technology:BioPlus Specialty Pharmacy Promotes Dr. Nick Maroulis to Vice President of Specialty Pharmacy Services 2Roche acquires Bina Technologies and enters the genomic informatics market 2Roche acquires Bina Technologies and enters the genomic informatics market 3Latin American Dental Biomaterial Market Will Expand at a 12 Percent Annual Growth Rate Through 2023 2Latin American Dental Biomaterial Market Will Expand at a 12 Percent Annual Growth Rate Through 2023 3BioPlus Specialty Pharmacy Expands ‘Regional Pharmaceutical Care Liaison’ Team 2BioPlus Specialty Pharmacy Expands ‘Regional Pharmaceutical Care Liaison’ Team 3
... , SAN DIEGO, Sept. 16 TriLink BioTechnologies, ... services. TriLink discontinued the service in May 2009 after ordering ... require it. However, strong customer feedback led TriLink to bring ... "We,ve learned that no other suppliers have exactly ...
... ... Internet,s number one destination for tile and stone how-to. , ... Atlanta, GA (PRWEB) September 16, 2009 - Tile Media Properties ... its first line of sealers, cleaners, and tile machines. The 10 year-old Atlanta-based company receives ...
... Sept. 16 Poniard Pharmaceuticals, Inc. (Nasdaq: PARD ... announced that Jerry McMahon, Ph.D., chairman and chief executive officer, ... Life Sciences Conference on Wednesday, September 23, 2009 at 3:00 ... York City. , , A live audio ...
Cached Biology Technology:TriLink BioTechnologies, Inc. Relaunches Oligonucleotide Radiolabeling Services 2The Tile Doctor Launches Inaugural Product Line 2The Tile Doctor Launches Inaugural Product Line 3Poniard Pharmaceuticals to Present at the 2009 UBS Global Life Sciences Conference 2
(Date:12/10/2014)... --Research and Markets ( http://www.researchandmarkets.com/research/xclcvw/biometrics_market ) ... Market in Japan 2014-2018" report to their ... The integration of biometrics and smart ... upgradation of the driver,s license is one of ... the aforementioned projects, biometrics is being used as ...
(Date:12/5/2014)... -- Tute Genomics, a leader in cloud-based solutions for genome ... led by UK-based Eurovestech. Peak Ventures and a number ... "We are at a pivotal time in ... seeks new approaches for the diagnosis, treatment and prevention ... and CEO of Tute Genomics. "One of the main ...
(Date:12/3/2014)... -- As part of our commitment to offering the ... announce the release of a new reader that will ... data that they need. The Atlas 2000 ... readers. Many such devices have serious shortcomings when it ... models force users to navigate numerous complicated steps in ...
Breaking Biology News(10 mins):Biometrics Market in Japan 2014-2018: Key Vendors are DDS, Fujitsu, Hitachi and NEC 2Tute Genomics Raises $2.3 Million to Scale Up Cloud-Based Genome Analytics and Accelerate Personalized Medicine 2Tute Genomics Raises $2.3 Million to Scale Up Cloud-Based Genome Analytics and Accelerate Personalized Medicine 3Inception Technologies to Release New Biometric Reader 2
... Bonn Institute for Forensic Medicine has recorded that the ... sexual offences within their catchment area increased 10-fold between ... Deutsches rzteblatt International, Burkhard Madea and Frank Musshoff ... for the most frequent substances ( Dtsch Arztebl Int ...
... should be built in Lund, Sweden, it has been announced ... last night (28 May), seven countries voted in support of ... a further two voting with the majority. The European ... for materials research, enabling scientists to study the atomic and ...
... of a USC-led research team say they,ve made a big ... and other biological materials one that may be a ... of a piece of synthetic antibody attached to a nanowire ... If the protein the antibody binds to is present in ...
Cached Biology News:Sweden to host 1.3 billion Euro research center 2A quicker, cheaper SARS virus detector -- one easily customizable for other targets 2
Carrier Serum...
Our original highly-purified, robust Taq Polymerase which delivers consistently high yields and minimal background...
... is a derivative of Taq DNA polymerase. ... aquaticus DNA polymerase. Expressed from a gene ... Met236, bypassing the 5'-3' exonuclease domain of ... a highly active and even more heat-stable ...
... Dinitro-5,5'-dithiodibenzoic acid , DTNB , Ellman's reagent ... , *CAS-No.: 69-78-3 *Storage: RT, ... a reactive grouping not present in the substrate, ... which will react directly with the product to ...
Biology Products: